Fed. Circ. Upholds PTAB Nix Of Blood-Clotting Patent
The Federal Circuit on Wednesday upheld a ruling by the Patent Trial and Appeal Board invalidating a patent for treating blood clotting by administering an active form of the blood thinner...To view the full article, register now.
Already a subscriber? Click here to view full article